Targeting Tropomyosin Receptor Kinase in Cutaneous CYLD Defective Tumors With Pegcantratinib: The TRAC Randomized Clinical Trial.

Danilenko, M, Stamp, E, Stocken, DD orcid.org/0000-0001-8031-1738 et al. (15 more authors) (2018) Targeting Tropomyosin Receptor Kinase in Cutaneous CYLD Defective Tumors With Pegcantratinib: The TRAC Randomized Clinical Trial. JAMA dermatology, 154 (8). pp. 913-921. ISSN 2168-6068

Abstract

Metadata

Authors/Creators:
  • Danilenko, M
  • Stamp, E
  • Stocken, DD https://orcid.org/0000-0001-8031-1738
  • Husain, A
  • Zangarini, M
  • Cranston, A
  • Stones, R
  • Sinclair, N
  • Hodgson, K
  • Bowett, SA
  • Roblin, D
  • Traversa, S
  • Plummer, R
  • Veal, G
  • Langtry, JAA
  • Ashworth, A
  • Burn, J
  • Rajan, N
Copyright, Publisher and Additional Information: © 2018 Danilenko M et al. JAMA Dermatology. This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. You are not required to obtain permission to reuse this article.
Dates:
  • Published: August 2018
  • Accepted: 18 April 2018
  • Published (online): 27 June 2018
Institution: The University of Leeds
Depositing User: Symplectic Publications
Date Deposited: 16 Jul 2018 10:27
Last Modified: 15 Aug 2018 17:55
Status: Published
Publisher: American Medical Association
Identification Number: https://doi.org/10.1001/jamadermatol.2018.1610
Related URLs:

Share / Export

Statistics